Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone.

Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone.

This study investigated the feasibility of targeting the free, unbound forms of prostate-specific antigen (fPSA) for in vivo imaging of prostate adenocarcinomas (PCa), as PSA is produced and secreted at abundance during every clinical stage and grade of PCa, including castration-resistant disease. W...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Evans-Axelsson, S, Ulmert, D, Örbom, A, Peterson, P, Nilsson, O, Wennerberg, J, Strand, J, Wingårdh, K, Olsson, T, Hagman, Z, Tolmachev, V, Bjartell, A, Lilja, H, Strand, SE
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2012

Míreanna comhchosúla

[Isoforms of free prostate-specific antigen]
de réir: Haese, A, et al.
Foilsithe / Cruthaithe: (2004)

Isoforms of free prostate-specific antigen
de réir: Haese, A, et al.
Foilsithe / Cruthaithe: (2004)

Prostate-specific antigen and prostate cancer: prediction, detection and monitoring.
de réir: Lilja, H, et al.
Foilsithe / Cruthaithe: (2008)

Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.
de réir: Vickers, A, et al.
Foilsithe / Cruthaithe: (2010)

Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: Case-control study
de réir: Vickers, A, et al.
Foilsithe / Cruthaithe: (2010)

Biology of prostate-specific antigen
de réir: Lilja, H
Foilsithe / Cruthaithe: (2003)

Biology of prostate-specific antigen.
de réir: Lilja, H
Foilsithe / Cruthaithe: (2003)

Free prostate-specific antigen outperforms total prostate-specific antigen as a predictor of prostate volume in patients without prostate cancer
de réir: Sinan Avci, et al.
Foilsithe / Cruthaithe: (2020-04-01)

Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen.
de réir: Ulmert, D, et al.
Foilsithe / Cruthaithe: (2012)

FREE/TOTAL PROSTATE SPECIFIC ANTIGEN RATIO AS PREDICTOR FOR PROSTATE CARCINOMA
de réir: Sajjad Ahmad, et al.
Foilsithe / Cruthaithe: (2017-08-01)

Cumulative prostate cancer risk assessment with the aid of the free-to-total prostate specific antigen ratio.
de réir: Aus, G, et al.
Foilsithe / Cruthaithe: (2004)

Time-resolved fluorescence imaging for specific and quantitative immunodetection of human kallikrein 2 and prostate-specific antigen in prostatic tissue sections.
de réir: Siivola, P, et al.
Foilsithe / Cruthaithe: (2000)

Prostate-specific antigen and prostate cancer: Prediction, detection and monitoring (Corrigendum) (Nature Reviews Cancer (2008) 8, (268-278))
de réir: Lilja, H, et al.
Foilsithe / Cruthaithe: (2008)

Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level.
de réir: Törnblom, M, et al.
Foilsithe / Cruthaithe: (2001)

Free Prostate-Specific Antigen Provides More Precise Data on Benign Prostate Volume Than Total Prostate-Specific Antigen in Korean Population
de réir: Hoon Choi, et al.
Foilsithe / Cruthaithe: (2013-06-01)

Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50.
de réir: Lilja, H, et al.
Foilsithe / Cruthaithe: (2011)

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
de réir: Nouira Yassin, et al.
Foilsithe / Cruthaithe: (2010-12-01)

Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Sweden.
de réir: Hugosson, J, et al.
Foilsithe / Cruthaithe: (2003)

Ratios of Free to Total Prostate-Specific Antigen and Total Prostate Specific Antigen to Protein Concentrations in Saliva and Serum of Healthy Men
de réir: Fahimeh Kamalian, et al.
Foilsithe / Cruthaithe: (2007-02-01)

Increase in percent free prostate-specific antigen in men with chronic kidney disease.
de réir: Bruun, L, et al.
Foilsithe / Cruthaithe: (2009)

Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancer.
de réir: Botchorishvili, G, et al.
Foilsithe / Cruthaithe: (2009)

Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancer.
de réir: Haese, A, et al.
Foilsithe / Cruthaithe: (2004)

Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 degrees C.
de réir: Ulmert, D, et al.
Foilsithe / Cruthaithe: (2006)

Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2.
de réir: Cao, Y, et al.
Foilsithe / Cruthaithe: (2002)

The Impact of the Percent of Residual Prostate-Specific Antigen on Metastasis-Free Survival in Patients with Persistent Prostate-Specific Antigen after Radical Prostatectomy
de réir: Dan Bee Lee, et al.
Foilsithe / Cruthaithe: (2023-01-01)

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men
de réir: Jeremy YC Teoh, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Prostatic specific antigen for prostate cancer detection
de réir: Lucas Nogueira, et al.
Foilsithe / Cruthaithe: (2009-10-01)

Benign prostatic hyperplasia and prostate-specific antigen
de réir: Pejčić Tomislav, et al.
Foilsithe / Cruthaithe: (2015-01-01)

Editorial comment. Association between glomerular filtration rate, free, total, and percent free prostate-specific antigen.
de réir: Christensson, A, et al.
Foilsithe / Cruthaithe: (2010)

Taxon-specific evolution of glandular kallikrein genes and identification of a progenitor of prostate-specific antigen.
de réir: Olsson, A, et al.
Foilsithe / Cruthaithe: (2004)

Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer
de réir: Becker, C, et al.
Foilsithe / Cruthaithe: (2003)

Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer.
de réir: Becker, C, et al.
Foilsithe / Cruthaithe: (2003)

Value of Prostate-Specific Antigen and Prostate-Specific Antigen Density in Detection of Prostate Cancer in an Iranian Population of Men
de réir: Mahyar Ghafoori, et al.
Foilsithe / Cruthaithe: (2009-08-01)

Percent-free prostate specific antigen is elevated in men on haemodialysis or peritoneal dialysis treatment.
de réir: Bruun, L, et al.
Foilsithe / Cruthaithe: (2003)

Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.
de réir: Klein, R, et al.
Foilsithe / Cruthaithe: (2012)

Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen.
de réir: Steuber, T, et al.
Foilsithe / Cruthaithe: (2002)

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer
de réir: Ahmad Anies Shahab, et al.
Foilsithe / Cruthaithe: (2013-03-01)

An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection.
de réir: Vickers, A, et al.
Foilsithe / Cruthaithe: (2011)

Expression of prostate-specific antigen (PSA) and human glandular kallikrein 2 (hK2) in ileum and other extraprostatic tissues.
de réir: Olsson, A, et al.
Foilsithe / Cruthaithe: (2005)

Empirical estimates of the lead time distribution for prostate cancer based on two independent representative cohorts of men not subject to prostate-specific antigen screening.
de réir: Savage, C, et al.
Foilsithe / Cruthaithe: (2010)